Related Experiment Video
Updated: Feb 12, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
944
Treating to Target-A Realistic Goal in Psoriasis?
Kenneth B Gordon1, April W Armstrong2, M Alan Menter3
1Professor and Chair Department of Dermatology Medical College of Wisconsin Milwaukee, Wisconsin.
Seminars in Cutaneous Medicine and Surgery
|April 4, 2018
Summary
Biologic therapies offer psoriasis relief, but suboptimal results frustrate patients. A treat-to-target strategy using patient-centered outcomes improves symptom management and disease control for better patient goals.
Area of Science:
- Dermatology
- Clinical Trials
- Psoriasis Treatment
Background:
- Biologic therapies can significantly improve Psoriasis Area and Severity Index (PASI) scores in psoriasis patients.
- Suboptimal treatment responses can lead to patient frustration and impact disease management.
Observation:
- Traditional clinical trial metrics like body surface area (BSA) and PASI scores are useful but may not fully capture patient experience.
- Patient-centered assessments are crucial for understanding individual treatment progress and satisfaction.
Findings:
- A treat-to-target strategy, incorporating patient-reported outcomes, can effectively manage psoriasis symptoms and halt disease progression.
- Tools such as the Dermatology Life Quality Index (DLQI) and Psoriasis Symptom Inventory (PSI) provide valuable patient insights.
Implications:
- Clinicians should integrate patient-reported outcomes into treatment plans for a more personalized approach to psoriasis care.
- Setting realistic, achievable goals based on patient-centered assessments enhances therapeutic success and patient well-being.
Keywords:
Body surface area (BSA)Dermatology Life Quality Index
(DLQI)Psoriasis Area and Severity Index (PASI)patient-reported outcomesquality of life (QOL)treat to targetMore Related Videos
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
545
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
545
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.4K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
03:20The Stanford Prison Experiment
24.8K
The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.
24.8K